Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polypharmacy in bipolar I disorder

D A Solomon1, G I Keitner, C E Ryan

  • 1Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA.

Psychopharmacology Bulletin
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.

AJNR. American journal of neuroradiology·2019
Same author

Preoperative MR Imaging to Differentiate Chordoid Meningiomas from Other Meningioma Histologic Subtypes.

AJNR. American journal of neuroradiology·2019
Same author

Review: Modelling the pathology and behaviour of frontotemporal dementia.

Neuropathology and applied neurobiology·2018
Same author

Adjunctive yoga v. health education for persistent major depression: a randomized controlled trial.

Psychological medicine·2017
Same author

Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation.

AJNR. American journal of neuroradiology·2017
Same author

Direct Cranial Nerve Involvement by Gliomas: Case Series and Review of the Literature.

AJNR. American journal of neuroradiology·2015
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

Bipolar I disorder treatment often fails with single mood stabilizers. Polypharmacy, using multiple drugs, is common but lacks extensive study, with some combinations showing no added benefit over monotherapy.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Therapeutics

Background:

  • Three primary mood stabilizers (lithium, valproate, carbamazepine) exist for bipolar I disorder maintenance.
  • Monotherapy with these agents frequently proves insufficient for effective patient outcomes.
  • Clinicians commonly employ polypharmacy, the use of multiple medications, to enhance treatment efficacy.

Purpose of the Study:

  • To review the current landscape of mood stabilizer polypharmacy in bipolar I disorder.
  • To assess the limited evidence supporting the efficacy of combined pharmacotherapy.
  • To highlight the need for further controlled research into polypharmacy's effectiveness.

Main Methods:

  • Review of existing literature, including controlled trials, case reports, and retrospective studies.

Related Experiment Videos

  • Analysis of data from the United States and Europe regarding polypharmacy prevalence.
  • Examination of specific drug combinations and their reported outcomes.

    • Main Results:

    • Few controlled trials exist, with some showing no advantage of specific combinations (e.g., lithium plus imipramine, lithium plus flupenthixol) over monotherapy.
    • Lithium plus carbamazepine may be comparable to lithium plus haloperidol for acute and continuation treatment.
    • Preliminary data suggest potential efficacy for combinations like lithium plus valproate, lithium plus carbamazepine, and valproate plus carbamazepine, as well as adjunctive use of clozapine or levothyroxine.

    Conclusions:

    • Polypharmacy is a prevalent strategy in bipolar I disorder management despite limited controlled evidence.
    • Further rigorous research is essential to validate the efficacy of drug combinations compared to monotherapy.
    • Clinicians must consider pharmacokinetic and pharmacodynamic principles when prescribing concurrent mood stabilizers.